Identification of Covalent Bromodomain Binders through DNA Display of Small Molecules
Open accessAbstract
The regulation of transcriptional programs by epigenetic readers (bromodomains) has been linked to the development of several pathologies. Notably, it has been implicated in the regulation of cellular growth and evasion of apoptosis, in cancer as well as in inflammation. The discovery of small‐molecule probes to dissect the role of bromodomains is thus important. We demonstrate that specific cysteine residues conserved across the bromodomains can be harnessed for covalent trapping. We report the discovery of two small molecules that form a covalent bond with cysteine residues conserved across the bromodomain family, analyze the subset of bromodomains that can be addressed through covalent binding, and show proteomic analyses enabled by the enrichment of bromodomains from native lysates.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cysteine-targeted DNA-encoded or protein-nucleic acid-encoded libraries have identified covalent ligands for bromodomains including PCAF and BRD4, as well as for JNK1, MEK2, and HER2.
“over the past 5 years, cysteine-targeted DNA-encoded or protein–nucleic acid-encoded libraries have been used to identify covalent ligands for bromodomains, including PCAF and BRD4, as well as for JNK1, MEK2 and HER2 (refs.160–162).”
From Advances in covalent drug discovery (2022) · cites this paper as [162]
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262 · see citing works
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557 · see citing works
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J., Baršytė-Lovejoy, D., Felletár, I., Volkmer, R., Müller, S., Pawson, T. J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.013 · Cited by 1,719 · see citing works
Self-citationQuantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684 · see citing works
Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., Li, S., Pan, Z., Thamm, D. H., Miller, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004594107 · Cited by 1,561 · see citing works
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
Li, D., Ambrogio, L., Shimamura, T., Kubo, S., Takahashi, M., Chirieac, L. R., Padera, R. F., Shapiro, G. I., Baum, A., Himmelsbach, F., et al. (2008) · Oncogene · doi:10.1038/onc.2008.109 · Cited by 1,447 · see citing works
Targeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,274 · see citing works
Targeting MYC dependence in cancer by inhibiting BET bromodomains
Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L., & Sims, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108190108 · Cited by 1,118 · see citing works
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Zhou, W., Ercan, D., Chen, L., Yun, C.-H., Li, D., Capelletti, M., Cortot, A. B., Chirieac, L., Iacob, R. E., Padera, R., et al. (2009) · Nature · doi:10.1038/nature08622 · Cited by 1,013 · see citing works
Deep proteome and transcriptome mapping of a human cancer cell line
Nagaraj, N., Wisniewski, J. R., Geiger, T., Cox, J., Kircher, M., Kelso, J., Pääbo, S., & Mann, M. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.81 · Cited by 979 · see citing works
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Liu, Q., Sabnis, Y. A., Zhao, Z., Zhang, T., Buhrlage, S. J., Jones, L. H., & Gray, N. S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.12.006 · Cited by 662 · see citing works
Small Molecule Modulators of Histone Acetyltransferase p300
Balasubramanyam, K., Swaminathan, V., Ranganathan, A., & Kundu, T. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301580200 · Cited by 518 · see citing works
Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors
Cohen, M. S., Zhang, C., Shokat, K. M., & Taunton, J. (2005) · Science · doi:10.1126/science1108367 · Cited by 509 · see citing works
Bromodomains as therapeutic targets
Müller, S., Filippakopoulos, P., & Knapp, S. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001992 · Cited by 445 · see citing works
Self-citationA road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors
Lanning, B. R., Whitby, L. R., Dix, M. M., Douhan, J., Gilbert, A. M., Hett, E. C., Johnson, T., Joslyn, C. M., Kath, J. C., Niessen, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1582 · Cited by 361 · see citing works
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Ciceri, P., Müller, S., O’Mahony, A., Fedorov, O., Filippakopoulos, P., Hunt, J. P., Lasater, E. A., Pallares, G., Picaud, S., Wells, C. D., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1471 · Cited by 345 · see citing works
Self-citationActivity-based protein profiling for biochemical pathway discovery in cancer
Nomura, D. K., Dix, M. M., & Cravatt, B. F. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2901 · Cited by 342 · see citing works
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Hay, D. A., Fedorov, O., Martin, S., Singleton, D. C., Tallant, C., Wells, C. D., Picaud, S., Philpott, M., Monteiro, O., Rogers, C. M., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412434f · Cited by 287 · see citing works
Self-citationDruggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
Vidler, L. R., Brown, N., Knapp, S., & Hoelder, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300346w · Cited by 281 · see citing works
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains
Picaud, S., Costa, D. D., Thanasopoulou, A., Filippakopoulos, P., Fish, P. V., Philpott, M., Fedorov, O., Brennan, P. E., Bunnage, M. E., Owen, D. R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3292 · Cited by 251 · see citing works
Self-citationLeproult, É., Barluenga, S., Moras, D., Wurtz, J., & Winssinger, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101396q · Cited by 196 · see citing works
Self-citationSelective Small Molecules Blocking HIV-1 Tat and Coactivator PCAF Association
Zeng, L., Li, J., Müller, M., Yan, S. X., Mujtaba, S., Pan, C., Wang, Z., & Zhou, M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044885g · Cited by 164 · see citing works
Novoa, A., Eierhoff, T., Topin, J., Varrot, A., Barluenga, S., Imberty, A., Römer, W., & Winssinger, N. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402831 · Cited by 102 · see citing works
Self-citationPNA-encoded chemical libraries
Zambaldo, C., Barluenga, S., & Winssinger, N. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.01.005 · Cited by 100 · see citing works
Self-citation1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain
Demont, E. H., Bamborough, P., Chung, C., Craggs, P. D., Fallon, D. J., Gordon, L. J., Grandi, P., Hobbs, C. I., Hussain, J., Jones, E. J., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5002932 · Cited by 95 · see citing works
Daguer, J., Zambaldo, C., Ciobanu, M., Morieux, P., Barluenga, S., & Winssinger, N. (2014) · Chemical Science · doi:10.1039/c4sc01654h · Cited by 91 · see citing works
Self-citationDaguer, J., Ciobanu, M., Álvarez, S., Barluenga, S., & Winssinger, N. (2011) · Chemical Science · doi:10.1039/c0sc00574f · Cited by 79 · see citing works
Self-citationSelf‐Assembled Small‐Molecule Microarrays for Protease Screening and Profiling
Urbina, H. D., Debaene, F., Jost, B., Bôle‐Feysot, C., Mason, D. E., Kuzmič, P., Harris, J. L., & Winssinger, N. (2006) · ChemBioChem · doi:10.1002/cbic.200600242 · Cited by 73 · see citing works
Self-citationChouikhi, D., Ciobanu, M., Zambaldo, C., Duplan, V., Barluenga, S., & Winssinger, N. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201201337 · Cited by 70 · see citing works
Self-citationHolmlund, T., Lindberg, M. J., Grandér, D., & Wallberg, A. E. (2012) · Leukemia · doi:10.1038/leu.2012.265 · Cited by 66 · see citing works
Wang, R., Li, C., Song, D., Zhao, G., Zhao, L., & Jing, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0151 · Cited by 55 · see citing works
Zhang, C., Tan, C. Y. J., Ge, J., Na, Z., Chen, G. Y. J., Uttamchandani, M., Sun, H., & Yao, S. Q. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201307803 · Cited by 45 · see citing works
Na, Y.-R., Han, K.-C., Park, H., & Yang, E. G. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.044 · Cited by 25 · see citing works
Novoa, A., Eierhoff, T., Topin, J., Varrot, A., Barluenga, S., Imberty, A., Römer, W., & Winssinger, N. (2014) · Angewandte Chemie · doi:10.1002/ange.201402831 · Cited by 20 · see citing works
Self-citationThe Pleiotropic Effects of Ethacrynic Acid
Somberg, J. C., & Molnár, J. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181961264 · Cited by 16 · see citing works
Daguer, J., Ciobanu, M., Barluenga, S., & Winssinger, N. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06880j · Cited by 15 · see citing works
Self-citationZhang, C., Tan, C. Y. J., Ge, J., Na, Z., Chen, G. Y. J., Uttamchandani, M., Sun, H., & Yao, S. Q. (2013) · Angewandte Chemie · doi:10.1002/ange.201307803 · Cited by 10 · see citing works
Winssinger, N., Gorska, K. I., Ciobanu, M., Daguer, J., & Barluenga, S. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-553-8_8 · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Advances in covalent drug discovery
Boike, L., Henning, N. J., & Nomura, D. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00542-z · Cited by 823 · see citing works
Neri, D., & Lerner, R. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012550 · Cited by 364 · see citing works
Open-Air Alkylation Reactions in Photoredox-Catalyzed DNA-Encoded Library Synthesis
Phelan, J. P., Lang, S. B., Sim, J., Berritt, S., Peat, A. J., Billings, K., Fan, L., & Molander, G. A. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b00669 · Cited by 316 · see citing works
Chemical Space of DNA-Encoded Libraries
Franzini, R. M., & Randolph, C. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01874 · Cited by 274 · see citing works
Covalent inhibitors: an opportunity for rational target selectivity
Lagoutte, R., Patouret, R., & Winssinger, N. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.05.008 · Cited by 138 · see citing works
Self-citationDNA-encoded chemical libraries: foundations and applications in lead discovery
Zimmermann, G., & Neri, D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.013 · Cited by 124 · see citing works
Strategies for developing DNA-encoded libraries beyond binding assays
Huang, Y., Li, Y., & Li, X. (2022) · Nature Chemistry · doi:10.1038/s41557-021-00877-x · Cited by 120 · see citing works
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases
Kulikowski, E., Rakai, B. D., & Wong, N. C. W. (2020) · Medicinal Research Reviews · doi:10.1002/med.21730 · Cited by 105 · see citing works
Yuen, L. H., & Franzini, R. M. (2016) · ChemBioChem · doi:10.1002/cbic.201600567 · Cited by 94 · see citing works
Chan, A. I., McGregor, L. M., Jain, T., & Liu, D. R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b04880 · Cited by 91 · see citing works
Future challenges with DNA-encoded chemical libraries in the drug discovery domain
Zhao, G., Huang, Y., Zhou, Y., Li, Y., & Li, X. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1614559 · Cited by 86 · see citing works
PNA as a Biosupramolecular Tag for Programmable Assemblies and Reactions
Barluenga, S., & Winssinger, N. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00109 · Cited by 77 · see citing works
Self-citationA Specific and Covalent JNK‐1 Ligand Selected from an Encoded Self‐Assembling Chemical Library
Zimmermann, G., Rieder, U., Bajic, D., Vanetti, S., Chaikuad, A., Knapp, S., Scheuermann, J., Mattarella, M., & Neri, D. (2017) · Chemistry – A European Journal · doi:10.1002/chem.201701644 · Cited by 77 · see citing works
Zambaldo, C., Daguer, J.-P., Saarbach, J., Barluenga, S., & Winssinger, N. (2016) · MedChemComm · doi:10.1039/c6md00242k · Cited by 75 · see citing works
Self-citationAn overview of DNA-encoded libraries: A versatile tool for drug discovery
Madsen, D. H., Azevedo, C., Micco, I., Petersen, L. K., & Hansen, N. J. V. (2020) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2020.03.001 · Cited by 69 · see citing works
Recent advances on the encoding and selection methods of DNA-encoded chemical library
Shi, B., Zhou, Y., Huang, Y., Zhang, J.-F., & Li, X. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.12.025 · Cited by 67 · see citing works
Corso, A. D., Catalano, M., Schmid, A. S., Scheuermann, J., & Neri, D. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201811650 · Cited by 67 · see citing works
Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development
Chen, J., Tang, P., Wang, Y., Wang, J., Yang, C., Li, Y., Yang, G., Wu, F., Zhang, J., & Ouyang, L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01835 · Cited by 62 · see citing works
Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70)
Li, X., Shao, H., Taylor, I. R., & Gestwicki, J. E. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160413140911 · Cited by 61 · see citing works
Kharenko, O. A., Patel, R. G., Brown, S. D., Calosing, C., White, A., Damodharan, L., Suto, R. K., Duffy, B. C., Kitchen, D. B., McLure, K. G., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00666 · Cited by 56 · see citing works
Jiang, L., Liu, S., Jia, X., Gong, Q., Wen, X., Lu, W., Yang, J., Wu, X., Wang, X., Suo, Y., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08852 · Cited by 52 · see citing works
Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors
Raj, U., Kumar, H., & Varadwaj, P. K. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1217276 · Cited by 51 · see citing works
Kielar, C., Reddavide, F. V., Tubbenhauer, S., Cui, M., Xu, X., Grundmeier, G., Zhang, Y., & Keller, A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806778 · Cited by 46 · see citing works
Scanning Protein Surfaces with DNA‐Encoded Libraries
Kunig, V. B. K., Potowski, M., Škopić, M. K., & Brunschweiger, A. (2020) · ChemMedChem · doi:10.1002/cmdc.202000869 · Cited by 43 · see citing works
Identification of Covalent Cyclic Peptide Inhibitors in mRNA Display
Iskandar, S. E., Chiou, L. F., Leisner, T. M., Shell, D. J., Norris-Drouin, J. L., Vaziri, C., Pearce, K. H., & Bowers, A. A. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04833 · Cited by 43 · see citing works
Mapping the Ligand Binding Landscape
Dickson, A. (2018) · bioRxiv · doi:10.1016/j.bpj.2018.09.021 · Cited by 44 · see citing works
Applications of Reactive Cysteine Profiling
Backus, K. M. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_120 · Cited by 38 · see citing works
Novel PTP1B inhibitors identified by DNA display of fragment pairs
Barluenga, S., Zambaldo, C., Ioannidou, H. A., Ciobanu, M., Morieux, P., Daguer, J., & Winssinger, N. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.102 · Cited by 40 · see citing works
Self-citationZhu, Z., Grady, L. C., Ding, Y., Lind, K. E., Davie, C. P., Phelps, C. B., & Evindar, G. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218808454 · Cited by 36 · see citing works
Schiedel, M., Moroglu, M., Ascough, D. M. H., Chamberlain, A. E. R., Kamps, J. J. A. G., Sekirnik, A. R., & Conway, S. J. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201812164 · Cited by 34 · see citing works
Integration of Lead Discovery Tactics and the Evolution of the Lead Discovery Toolbox
Leveridge, M. V., Chung, C., Gross, J. W., Phelps, C. B., & Green, D. V. S. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218778503 · Cited by 31 · see citing works
Rational Design Strategies in DNA‐Encoded Libraries for Drug Discovery
Wang, X., Li, L., Shen, X., & Lu, X. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202511839 · Cited by 29 · see citing works
D’Ascenzio, M., Pugh, K., Konietzny, R., Berridge, G., Tallant, C., Hashem, S., Monteiro, O., Thomas, J. R., Schirle, M., Knapp, S., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807825 · Cited by 29 · see citing works
Self-citationCovalent hits and where to find them
Lucas, S. C. C., Blackwell, J. H., Hewitt, S. H., Semple, H., Whitehurst, B. C., & Xu, H. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.01.003 · Cited by 30 · see citing works
Recent Advances on the Selection Methods of DNA‐Encoded Libraries
Huang, Y., & Li, X. (2021) · ChemBioChem · doi:10.1002/cbic.202100144 · Cited by 28 · see citing works
DNA-Encoded Library Technology─A Catalyst for Covalent Ligand Discovery
Dickson, P. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00803 · Cited by 27 · see citing works
Small-Molecule Modulators of the ATPase VCP/p97 Affect Specific p97 Cellular Functions
Conchas, A. F., Saarbach, J., Daguer, J., Cieren, A., Barluenga, S., Winssinger, N., & Gotta, M. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00832 · Cited by 26 · see citing works
Self-citationAn mRNA Display Approach for Covalent Targeting of a Staphylococcus aureus Virulence Factor
Wang, S., Woods, E. C., Jo, J., Zhu, J., Hansel-Harris, A., Holcomb, M., Llanos, M. A., Pedowitz, N. J., Upadhyay, T., Bennett, J. M., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c15713 · Cited by 21 · see citing works
DNA display of glycoconjugates to emulate oligomeric interactions of glycans
Novoa, A., & Winssinger, N. (2015) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.11.81 · Cited by 21 · see citing works
Self-citationTarget 2035 – an update on private sector contributions
Ackloo, S. Z., Antolín, A. A., Bartolomé, J. M., Beck, H., Bullock, A. N., Betz, U. A. K., Böttcher, J., Brown, P. J., Chaturvedi, M., Crisp, A., et al. (2023) · RSC Medicinal Chemistry · doi:10.1039/d2md00441k · Cited by 19 · see citing works
Self-citationOpportunities and challenges for the development of covalent chemical immunomodulators
Backus, K. M., Cao, J. X., & Maddox, S. M. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.05.050 · Cited by 21 · see citing works
Advancing small-molecule drug discovery by encoded dual-display technologies
Lessing, A., Petrov, D. D., & Scheuermann, J. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.08.006 · Cited by 20 · see citing works
Corso, A. D., Catalano, M., Schmid, A. S., Scheuermann, J., & Neri, D. (2018) · Angewandte Chemie · doi:10.1002/ange.201811650 · Cited by 19 · see citing works
The Current Toolbox for Covalent Inhibitors: From Hit Identification to Drug Discovery
You, M., Liu, H. S., & Li, C. (2025) · JACS Au · doi:10.1021/jacsau.5c01134 · Cited by 17 · see citing works
Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
Yu, L., Lee, H., Rho, S. B., Park, M. K., & Lee, C. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076712 · Cited by 16 · see citing works
Synthesis of deoxyelephantopin analogues
Lagoutte, R., Serba, C., & Winssinger, N. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.132 · Cited by 15 · see citing works
Self-citationKielar, C., Reddavide, F. V., Tubbenhauer, S., Cui, M., Xu, X., Grundmeier, G., Zhang, Y., & Keller, A. (2018) · Angewandte Chemie · doi:10.1002/ange.201806778 · Cited by 13 · see citing works
Lysine‐Targeting, Covalent Inhibitors of Bromodomain BD1 of BET Proteins in Live Cells and Animals
Li, T., Zhang, W., Wang, Y., Xu, G., Miao, F., Chen, P., Tang, G., Ze, X., Xiang, J., Yan, J., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202424832 · Cited by 12 · see citing works
Best Practices for Design and Characterization of Covalent Chemical Probes
Gabizon, R., Resnick, E., & London, N. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00069 · Cited by 10 · see citing works
Daguer, J., Gonse, A., Shchukin, Y., Soler, L. F., Barluenga, S., & Winssinger, N. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116282 · Cited by 10 · see citing works
Self-citationRecent advances in DNA-encoded libraries: From covalent targeting to protein profiling
Jin, R., & Lu, X. (2025) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2025.103163 · Cited by 10 · see citing works
Covalent fragment libraries in drug discovery—Design, synthesis, and screening methods
Hocking, B. J. W., Armstrong, A., & Mann, D. J. (2023) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2023.10.003 · Cited by 9 · see citing works
D’Ascenzio, M., Pugh, K., Konietzny, R., Berridge, G., Tallant, C., Hashem, S., Monteiro, O., Thomas, J. R., Schirle, M., Knapp, S., et al. (2018) · Angewandte Chemie · doi:10.1002/ange.201807825 · Cited by 6 · see citing works
Self-citationApplied Biophysics for Bromodomain Drug Discovery
Pomerantz, W. C. K., Johnson, J. A., & Ycas, P. D. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2019_79 · Cited by 5 · see citing works
Covalent chemistry in targeted protein degradation
Tan, J., Liang, Y., Shao, S., & Shen, Y. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115777 · Cited by 4 · see citing works
Meyer, A. G., Smith, J. A., Hyland, C. J. T., Williams, C. C., Bissember, A. C., & Nicholls, T. P. (2016) · Progress in heterocyclic chemistry · doi:10.1016/b978-0-08-100755-6.00016-8 · Cited by 4 · see citing works
Sameshima, T., Tanaka, Y., & Miyahisa, I. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00190 · Cited by 3 · see citing works
Schiedel, M., Moroglu, M., Ascough, D. M. H., Chamberlain, A. E. R., Kamps, J. J. A. G., Sekirnik, A. R., & Conway, S. J. (2019) · Angewandte Chemie · doi:10.1002/ange.201812164 · Cited by 3 · see citing works
Systematic Evaluation of Electrophile Reactivity and Stability for Covalent DNA‐Encoded Libraries
Puff, J., Assoni, G., Zhao, J., Zhang, Q., Ma, Z., Liu, H., Cui, W., Satz, A. L., Su, W., Kuai, L., et al. (2026) · Helvetica Chimica Acta · doi:10.1002/hlca.70064 · Cited by 2 · see citing works
Rational Design Strategies in DNA‐Encoded Libraries for Drug Discovery
Wang, X., Li, L., Shen, X., & Lu, X. (2025) · Angewandte Chemie · doi:10.1002/ange.202511839 · Cited by 2 · see citing works
Jacinto, M. P., Heidenreich, D. J., Müller, S., & Greenberg, M. M. (2022) · ChemBioChem · doi:10.1002/cbic.202200373 · Cited by 1 · see citing works
Self-citationLysine‐Targeting, Covalent Inhibitors of Bromodomain BD1 of BET Proteins in Live Cells and Animals
Li, T., Zhang, W., Wang, Y., Xu, G., Miao, F., Chen, P., Tang, G., Ze, X., Xiang, J., Yan, J., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202424832 · Cited by 1 · see citing works
Selection Strategies in DNA-Encoded Libraries
Gui, Y., & Li, X. (2022) · Topics in medicinal chemistry · doi:10.1007/7355_2022_149 · Cited by 1 · see citing works
High Throughput Screening Methods for PPI Inhibitor Discovery
Doyle, S. P., Mo, X., Qian, K., Cicka, D., Niu, Q., & Fu, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00049 · Cited by 1 · see citing works
PNA-Encoded Synthesis (PES) and DNA Display of Small Molecule Libraries
Saarbach, J., Gajić, J., Barluenga, S., & Winssinger, N. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0243-0_7
Self-citationApplication of DELs for E3 Ligase Ligand Discovery and Targeted Protein Degradation
Malone, M. L., Sanchez, N. A., Hu, S. L., & Phelps, C. B. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016032-00134
BindingDB Entry 50013495: Dual Bcl-X
BindingDB (2022) · UC San Diego · doi:10.7270/q2t157dk
BindingDB Entry 50012499: Novel PTP1B inhibitors identified by DNA display of fragment pairs.
BindingDB (2022) · UC San Diego · doi:10.7270/q2kk9ghp
BindingDB Entry 50009804: Chemical Space of DNA-Encoded Libraries.
BindingDB (2021) · UC San Diego · doi:10.7270/q2n58qv5
- Authors
- Daguer, J., Zambaldo, C., Abegg, D., Barluenga, S., Tallant, C., Müller, S., Adibekian, A., & Winssinger, N.
- Affiliations
- University of Geneva (CH)
- University of Oxford (GB)
- Corresponding author
- Winssinger, Nicolas
- ORCID
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2015-03-13
- Volume
- 54
- Issue
- 20
- Pages
- 6057-6061
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2106187776
- Cited by
- 65
- References
- 38
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 2 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 6 · 2019: 7 · 2018: 12 · 2017: 5 · 2016: 8 · 2015: 3
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (092809/Z/10/Z)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Keywords
- bromodomain, covalent inhibitors, cysteine residues, chemical probes, epigenetic reader protein, transcriptional regulation, bromodomain inhibitors
- MeSH terms
- Binding Sites, Cysteine, DNA, Ethacrynic Acid, Humans, Models, Molecular, Molecular Probes, Molecular Structure, Protein Structure, Tertiary, Proteomics, Epigenesis, Genetic, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review